Ronna Hauser, PharmD, Senior Vice President of Policy & Pharmacy Affairs at NCPA, provides insights into President Trump’s most recent executive order regarding manufacturer drug prices.
Ronna Hauser, PharmD
Advertisement
Senior Vice President of Policy & Pharmacy Affairs at the National Community Pharmacists Association (NCPA)
Articles by Ronna Hauser, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
TrumpRx Promising Direct-to-Consumer Drugs for Discounted Prices
2
FDA Enforces Stricter Vaccine Development, Linking COVID Vaccine to Pediatric Deaths
3
Q&A: TrumpRx Could Change the Way Pharmacies, PBMs Do Business
4
New Research Highlights Dietary Interventions to Potentially Manage Asthma
5
